Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT

Affiliations

• ¹ Hôpital Saint-Louis, APHP, Université de Paris Cité, Paris, France. [email protected].
• ² Deptartment of Biology, University of Rome Tor Vergata, Rome, Italy.
• ³ EBMT Leiden Study Unit, Leiden, The Netherlands.
• ⁴ University Hospital | Basel, Basel, Switzerland.
• ⁵ King's College Hospital, London, UK.
• ⁶ University Hospital of Wales, Cardiff, UK.
• ⁷ HUCH Comprehensive Cancer Center, Helsinki, Finland.
• ⁸ University of Heidelberg, Heidelberg, Germany.
• ⁹ Leiden University Hospital, Leiden, The Netherlands.
• ¹⁰ Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
• ¹¹ Bristol Royal Hospital for Children, Bristol, UK.
• ¹² ASST Papa Giovanni XXIII, Bergamo, Italy.
• ¹³ University Hospital | Essen, Duesseldorf, Germany.
• ¹⁴ Northern Centre for Bone Marrow Transplantation, Newcastle, England.
• ¹⁵ Hannover Medical School, Hannover, Germany.
• ¹⁶ Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France.
• ¹⁷ CHU Nice-Hôpital de l'ARCHET, Nice, France.
• ¹⁸ Department of Oncology/Hematology, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, 20089, Milan, Italy.
• ¹⁹ Instituto de Biomedicina de Sevilla IBIS, CSIC, Hospital Universitario Virgen del Rocío Universidad de Sevilla, Sevilla, Spain.
• ²⁰ Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
• ²¹ Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
• ²² University Clinical Centre Medical University of Warsaw, Warsaw, Poland.
• ²³ University College London Hospitals NHS Trust, London, UK.
• ²⁴ Department of Hematology, Hospital Clínico Universitario, Valencia, Spain.
• ²⁵ University College Hospital London, London, UK.